ID SPXN_HUMAN Reviewed; 116 AA. AC Q9BT56; B3KND6; DT 27-SEP-2005, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2001, sequence version 1. DT 24-JAN-2024, entry version 130. DE RecName: Full=Spexin; DE AltName: Full=NPQ; DE AltName: Full=Neuropeptide Q; DE AltName: Full=Spexin hormone; DE Contains: DE RecName: Full=Spexin-1; DE Contains: DE RecName: Full=Spexin-2; DE AltName: Full=NPQ 53-70; DE Flags: Precursor; GN Name=SPX; Synonyms=C12orf39; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RX PubMed=19132080; DOI=10.1371/journal.pcbi.1000258; RA Sonmez K., Zaveri N.T., Kerman I.A., Burke S., Neal C.R., Xie X., RA Watson S.J., Toll L.; RT "Evolutionary sequence modeling for discovery of peptide hormones."; RL PLoS Comput. Biol. 5:E1000258-E1000258(2009). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Embryo; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Uterus; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP FUNCTION (SPEXIN-1), SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=17284679; DOI=10.1101/gr.5755407; RA Mirabeau O., Perlas E., Severini C., Audero E., Gascuel O., Possenti R., RA Birney E., Rosenthal N., Gross C.; RT "Identification of novel peptide hormones in the human proteome by hidden RT Markov model screening."; RL Genome Res. 17:320-327(2007). RN [6] RP SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=19193193; DOI=10.1042/bsr20080156; RA Wan B., Wang X.R., Zhou Y.B., Zhang X., Huo K., Han Z.G.; RT "C12ORF39, a novel secreted prot ein with a typical amidation processing RT signal."; RL Biosci. Rep. 30:1-10(2010). RN [7] RP TISSUE SPECIFICITY. RX PubMed=23080164; DOI=10.1007/978-94-007-4584-1_29; RA Porzionato A., Rucinski M., Macchi V., Stecco C., Sarasin G., Sfriso M.M., RA Di Giulio C., Malendowicz L.K., De Caro R.; RT "Spexin is expressed in the carotid body and is upregulated by postnatal RT hyperoxia exposure."; RL Adv. Exp. Med. Biol. 758:207-213(2012). RN [8] RP PROTEOLYTIC PROCESSING (SPEXIN-1 AND SPEXIN-2), AND AMIDATION AT GLN-49. RX PubMed=22038051; DOI=10.1096/fj.11-192831; RA Toll L., Khroyan T.V., Sonmez K., Ozawa A., Lindberg I., McLaughlin J.P., RA Eans S.O., Shahien A.A., Kapusta D.R.; RT "Peptides derived from the prohormone proNPQ/spexin are potent central RT modulators of cardiovascular and renal function and nociception."; RL FASEB J. 26:947-954(2012). RN [9] RP FUNCTION (SPEXIN-1), AND PHYLOGENY. RX PubMed=24517231; DOI=10.1210/en.2013-2106; RA Kim D.K., Yun S., Son G.H., Hwang J.I., Park C.R., Kim J.I., Kim K., RA Vaudry H., Seong J.Y.; RT "Coevolution of the spexin/galanin/kisspeptin family: Spexin activates RT galanin receptor type II and III."; RL Endocrinology 155:1864-1873(2014). RN [10] RP SUBCELLULAR LOCATION, AND INDUCTION. RX PubMed=24550067; DOI=10.1002/oby.20725; RA Walewski J.L., Ge F., Lobdell H. IV, Levin N., Schwartz G.J., RA Vasselli J.R., Pomp A., Dakin G., Berk P.D.; RT "Spexin is a novel human peptide that reduces adipocyte uptake of long RT chain fatty acids and causes weight loss in rodents with diet-induced RT obesity."; RL Obesity 22:1643-1652(2014). CC -!- FUNCTION: Plays a role as a central modulator of cardiovascular and CC renal function and nociception. Also plays a role in energy metabolism CC and storage. Inhibits adrenocortical cell proliferation with minor CC stimulation on corticosteroid release (By similarity). {ECO:0000250}. CC -!- FUNCTION: [Spexin-1]: Acts as a ligand for galanin receptors GALR2 and CC GALR3 (PubMed:17284679, PubMed:24517231). Intracerebroventricular CC administration of the peptide induces an increase in arterial blood CC pressure, a decrease in both heart rate and renal excretion and delayed CC natriuresis. Intraventricular administration of the peptide induces CC antinociceptive activity. Also induces contraction of muscarinic-like CC stomach smooth muscles. Intraperitoneal administration of the peptide CC induces a reduction in food consumption and body weight. Inhibits long CC chain fatty acid uptake into adipocytes (By similarity). {ECO:0000250, CC ECO:0000269|PubMed:17284679, ECO:0000269|PubMed:24517231}. CC -!- FUNCTION: [Spexin-2]: Intracerebroventricular administration of the CC peptide induces a decrease in heart rate, but no change in arterial CC pressure, and an increase in urine flow rate. Intraventricular CC administration of the peptide induces antinociceptive activity (By CC similarity). {ECO:0000250}. CC -!- INTERACTION: CC Q9BT56; Q6IN84: MRM1; NbExp=3; IntAct=EBI-17975052, EBI-5454865; CC -!- SUBCELLULAR LOCATION: Secreted. Secreted, extracellular space. CC Cytoplasmic vesicle, secretory vesicle. Note=Secreted via the classical CC ER/Golgi-dependent pathway into the extracellular medium largely as a CC full-length protein without the signal peptide, and not as a hydrolyzed CC and amidated peptide (PubMed:19193193, PubMed:17284679). Localized CC extracellularly surrounding the villous trophoblastic cells. Detected CC in the serum. CC -!- TISSUE SPECIFICITY: Expressed in the type I glomic cells within the CC carotid body (at protein level). Expressed predominantly in pancreas, CC testis, kidney, brain and placenta. Expressed in submucosal layer of CC esophagus and stomach fundus. {ECO:0000269|PubMed:17284679, CC ECO:0000269|PubMed:19132080, ECO:0000269|PubMed:19193193, CC ECO:0000269|PubMed:23080164}. CC -!- INDUCTION: Down-regulated in omental and subcutaneous fat of obese CC subjects. {ECO:0000269|PubMed:24550067}. CC -!- SIMILARITY: Belongs to the spexin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK027273; BAG51298.1; -; mRNA. DR EMBL; AK075342; BAG52117.1; -; mRNA. DR EMBL; CH471094; EAW96444.1; -; Genomic_DNA. DR EMBL; BC004336; AAH04336.1; -; mRNA. DR CCDS; CCDS31757.1; -. DR RefSeq; NP_085049.1; NM_030572.3. DR PDB; 7XJL; EM; 3.50 A; A=36-49. DR PDBsum; 7XJL; -. DR AlphaFoldDB; Q9BT56; -. DR SMR; Q9BT56; -. DR BioGRID; 123297; 34. DR IntAct; Q9BT56; 1. DR STRING; 9606.ENSP00000256969; -. DR BioMuta; SPX; -. DR jPOST; Q9BT56; -. DR MassIVE; Q9BT56; -. DR PaxDb; 9606-ENSP00000256969; -. DR PeptideAtlas; Q9BT56; -. DR ProteomicsDB; 78952; -. DR Antibodypedia; 2438; 27 antibodies from 11 providers. DR DNASU; 80763; -. DR Ensembl; ENST00000256969.7; ENSP00000256969.2; ENSG00000134548.11. DR GeneID; 80763; -. DR KEGG; hsa:80763; -. DR MANE-Select; ENST00000256969.7; ENSP00000256969.2; NM_030572.4; NP_085049.1. DR UCSC; uc001rfa.2; human. DR AGR; HGNC:28139; -. DR CTD; 80763; -. DR DisGeNET; 80763; -. DR GeneCards; SPX; -. DR HGNC; HGNC:28139; SPX. DR HPA; ENSG00000134548; Tissue enriched (adipose). DR MIM; 619246; gene. DR neXtProt; NX_Q9BT56; -. DR OpenTargets; ENSG00000134548; -. DR PharmGKB; PA143485369; -. DR VEuPathDB; HostDB:ENSG00000134548; -. DR eggNOG; ENOG502SAD1; Eukaryota. DR GeneTree; ENSGT00390000012501; -. DR HOGENOM; CLU_169090_0_0_1; -. DR InParanoid; Q9BT56; -. DR OMA; LETRSHN; -. DR OrthoDB; 4588475at2759; -. DR PhylomeDB; Q9BT56; -. DR TreeFam; TF333402; -. DR PathwayCommons; Q9BT56; -. DR SignaLink; Q9BT56; -. DR SIGNOR; Q9BT56; -. DR BioGRID-ORCS; 80763; 13 hits in 1143 CRISPR screens. DR GenomeRNAi; 80763; -. DR Pharos; Q9BT56; Tbio. DR PRO; PR:Q9BT56; -. DR Proteomes; UP000005640; Chromosome 12. DR RNAct; Q9BT56; Protein. DR Bgee; ENSG00000134548; Expressed in body of pancreas and 138 other cell types or tissues. DR ExpressionAtlas; Q9BT56; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0031045; C:dense core granule; IDA:UniProtKB. DR GO; GO:0005615; C:extracellular space; IDA:UniProtKB. DR GO; GO:0030133; C:transport vesicle; IEA:UniProtKB-SubCell. DR GO; GO:0005184; F:neuropeptide hormone activity; IMP:UniProtKB. DR GO; GO:0044539; P:long-chain fatty acid import into cell; ISS:UniProtKB. DR GO; GO:0032099; P:negative regulation of appetite; ISS:UniProtKB. DR GO; GO:0010459; P:negative regulation of heart rate; ISS:UniProtKB. DR GO; GO:0035814; P:negative regulation of renal sodium excretion; ISS:UniProtKB. DR GO; GO:1904306; P:positive regulation of gastro-intestinal system smooth muscle contraction; IMP:UniProtKB. DR GO; GO:0003084; P:positive regulation of systemic arterial blood pressure; ISS:UniProtKB. DR GO; GO:0051930; P:regulation of sensory perception of pain; ISS:UniProtKB. DR InterPro; IPR028126; Spexin. DR PANTHER; PTHR28590; SPEXIN; 1. DR PANTHER; PTHR28590:SF1; SPEXIN; 1. DR Pfam; PF15171; Spexin; 1. DR Genevisible; Q9BT56; HS. PE 1: Evidence at protein level; KW 3D-structure; Amidation; Cleavage on pair of basic residues; KW Cytoplasmic vesicle; Hormone; Reference proteome; Secreted; Signal. FT SIGNAL 1..26 FT /evidence="ECO:0000255" FT CHAIN 27..116 FT /note="Spexin" FT /id="PRO_0000430213" FT PROPEP 27..35 FT /id="PRO_0000363216" FT PEPTIDE 36..49 FT /note="Spexin-1" FT /id="PRO_0000042159" FT PROPEP 50..116 FT /id="PRO_0000363217" FT PEPTIDE 53..70 FT /note="Spexin-2" FT /id="PRO_0000430214" FT PROPEP 74..116 FT /id="PRO_0000430215" FT REGION 55..77 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 55..69 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT SITE 35..36 FT /note="Cleavage; by prohormone convertase 2" FT SITE 52..53 FT /note="Cleavage; by prohormone convertase 2" FT SITE 72..73 FT /note="Cleavage; by prohormone convertase 2" FT MOD_RES 49 FT /note="Glutamine amide" FT /evidence="ECO:0000269|PubMed:22038051" FT HELIX 39..46 FT /evidence="ECO:0007829|PDB:7XJL" SQ SEQUENCE 116 AA; 13302 MW; CCBC3E7BD22E357E CRC64; MKGLRSLAAT TLALFLVFVF LGNSSCAPQR LLERRNWTPQ AMLYLKGAQG RRFISDQSRR KDLSDRPLPE RRSPNPQLLT IPEAATILLA SLQKSPEDEE KNFDQTRFLE DSLLNW //